Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TRPA1 | O75762 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.47 |
| ▸ | TSHR | P16473 | 1/20 | 0.47 |
| ▸ | CES2 | O00748 | 1/20 | 0.31 |
| ▸ | CES1 | P23141 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19002957 | 0.89 | TRPA1 (0.40) | TRPA1ALDH1A1TSHR | |
| SCHEMBL642402 | 0.86 | IDO1 (0.40) | TRPA1ALDH1A1TSHR | |
| SCHEMBL10064215 | 0.83 | TRPA1 (0.36) | TRPA1ALDH1A1TSHR | |
| SCHEMBL625710 | 0.83 | TSHR (0.41) | TRPA1ALDH1A1TSHR | |
| SCHEMBL1229742 | 0.83 | ACHE (0.48) | TRPA1ALDH1A1TSHRCES2CES1 | |
| SCHEMBL23654211 | 0.83 | LOXL2 (0.36) | TRPA1ALDH1A1TSHR | |
| SCHEMBL15574021 | 0.83 | TRPA1 (0.36) | TRPA1ALDH1A1TSHR | |
| SCHEMBL18640647 | 0.83 | PTGS2 (0.44) | TRPA1ALDH1A1TSHR | |
| SCHEMBL20715836 | 0.83 | TRPA1 (0.36) | TRPA1ALDH1A1TSHR | |
| SCHEMBL29482741 | 0.83 | TRPA1 (0.36) | TRPA1ALDH1A1TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1510 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260137791-A1 | BICYCLIC PEPTIDE LIGANDS SPECIFIC FOR PD-L1 | Bicyclerd Limited (GB) | 2026-05-21 | — | — | US | claimed |
| EP-4745151-A1 | FIBROBLAST ACTIVATION PROTEIN LIGAND AND USE THEREOF | Jiangsu Hengrui Pharmaceuticals Co., Ltd. (CN) | 2026-05-20 | — | — | EP | claimed |
| CN-122037144-A | Porphyrin-based super-crosslinked polymer catalyst modified by quaternary phosphonium salt ionic liquid and application thereof | 南京工业大学 | 2026-05-15 | — | — | CN | claimed |
| CN-122004208-A | Application of quaternized copolymer in preparation of pesticide slow-release agent and pesticide slow-release agent | 浙江农林大学 | 2026-05-12 | — | — | CN | claimed |
| US-12590181-B2 | Hydrophobically-modified associative thickener polymers process for the preparation and uses thereof | HERCULES LLC (US) | 2026-03-31 | — | — | US | claimed |
| EP-3463630-B1 | PROCESS FOR THE PRODUCTION OF SOLVENT STABLE POLYMERIC MEMBRANES | IP2IPO INNOVATIONS LTD (GB) | 2026-02-25 | — | — | EP | claimed |
| US-12551567-B2 | Bicyclic peptide ligands specific for PD-L1 | Bicyclerd Limited (GB) | 2026-02-17 | — | — | US | claimed |
| US-12552837-B2 | Bicyclic peptide ligands with detectable moieties and uses thereof | Bicyclerd Limited (GB) | 2026-02-17 | — | — | US | claimed |
| EP-4676633-A1 | DUAL-LAYER HOLLOW FIBRE MEMBRANE | Divigas Pte Ltd (SG) | 2026-01-14 | — | — | EP | claimed |
| US-12491253-B2 | Bicyclic peptide ligands specific for MT1-MMP | Bicyclerd Limited (GB) | 2025-12-09 | — | — | US | claimed |
| CN-103943805-B | Lithium rechargeable battery and barrier film thereof | NINGDE AMPEREX TECHNOLOGY LTD. (CN) | 2016-04-06 | — | — | CN | claimed |
| CN-103657610-B | Porous polymer adsorbent for selectively adsorbing carbon dioxide and preparation method thereof | NANJING TECH UNIVERSITY (CN) | 2016-01-06 | — | — | CN | claimed |
| US-20140330031-A1 | RESIST FOR ELECTRON BEAM AND OPTICAL LITHOGRAPHY | COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) | 2014-11-06 | — | — | US | claimed |
| CN-103943805-A | Lithium ion secondary battery and diaphragm thereof | NINGDE AMPEREX TECHNOLOGY LTD | 2014-07-23 | — | — | CN | claimed |
| WO-2013084247-A1 | RESIST FOR ELECTRON BEAM AND OPTICAL LITHOGRAPHY | COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) | 2013-06-13 | — | — | WO | claimed |
| US-6221991-B1 | STAR POLYMER | FMC CORPORATION | 2001-04-24 | — | — | US | claimed |
| US-5900464-A | USING AN ORGANOMETALLIC COMPOUND AS PROMOTER | FMC CORPORATION (US) | 1999-05-04 | — | — | US | claimed |
| EP-0620500-A2 | Resist and pattern formation using the same | HITACHI, LTD. (JP) | 1994-10-19 | — | — | EP | claimed |
| EP-0456317-B1 | CATALYST COMPOSITIONS AND POLYMERIZATION PROCESS, HEXAKISPHOSPHINES AND HEXAHALO COMPOUNDS | SHELL INTERNATIONALE RESEARCHMAATSCHAPPIJ B.V. (NL) | 1993-08-25 | — | — | EP | claimed |
| EP-0456317-A1 | Catalyst compositions and polymerization process, hexakisphosphines and hexahalo compounds | SHELL INTERNATIONALE RESEARCHMAATSCHAPPIJ B.V. (NL) | 1991-11-13 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12552837-B2 | Bicyclic peptide ligands with detectable moieties and uses thereof | SSTR2, FPR1, NPR1 | TRPA1 3657/4885ALDH1A1 4302/4885TSHR 147/4885 |
| US-12551567-B2 | Bicyclic peptide ligands specific for PD-L1 | PDCD1LG2, CD274, PDCD1 | TRPA1 4576/4885ALDH1A1 4526/4885TSHR 935/4885 |
| US-12590181-B2 | Hydrophobically-modified associative thickener polymers process for the preparation and uses thereof | PHOSPHO1, H1-10, H1-0 | TRPA1 553/4885ALDH1A1 4014/4885TSHR 3461/4885 |
| US-20260137791-A1 | BICYCLIC PEPTIDE LIGANDS SPECIFIC FOR PD-L1 | PDCD1LG2, CD274, PDCD1 | TRPA1 4657/4885ALDH1A1 3312/4885TSHR 931/4885 |
| US-12491253-B2 | Bicyclic peptide ligands specific for MT1-MMP | MMEL1, MMP3, TIMP3 | TRPA1 4166/4885ALDH1A1 2057/4885TSHR 3421/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.